A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias

American Journal of Hematology

Volumn 83, Issue 5, 2008, Pages 349-354

  Goldaniga, Maria Cecilia ^a,h   Ferrario, Andrea ^a   Cortelazzo, Sergio ^b   Guffanti, Andrea ^c   Pavone, Enzo ^d   Ambrosetti, Achille ^e   Marcheselli, Luigi ^f   Rossi, Francesca ^a   Luminari, Stefano ^f   Rossi, Andrea ^b   Cro, Lilla ^g   Federico, Massimo ^f   Deliliers, Giorgio Lambertenghi ^a   Baldini, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^h Unit Operativa Ematologia 1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; LACTATE DEHYDROGENASE; PURINE DERIVATIVE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CELL STRUCTURE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLENOMEGALY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, NEOPLASM; B-LYMPHOCYTE SUBSETS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; RETROSPECTIVE STUDIES; SPLENIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 42949115797     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21065     Document Type: Article

References (31)

1. Bennet JM, Catovsky D, Daniel M-T, et al. The French-American-British (FAB) cooperative group. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989;42:567-584.
2. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;12:3835-3849.
3. Ugo V, Leporrier N, Salaun V, et al. Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leuk Lymphoma 2006;47:2088-2095.
4. Zent CS. Chronic B-cell lymphoproliferative disorders: How many diseases? Leuk Lymphoma 2006;47:2006-2007.
5. Muller-Hermelink HK, Catovsky D, Montserrat E, Harris NL. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Jaffe E, Harris N, Stein H, Vardiman J, editors. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp 127-130
6. Nowakowski GS, Dewald GW, Hoyer JD, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005;130:36-42.
7. Cro L, Guffanti A, Colombi M, et al. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia 2003;17:125-132.
8. Huang JC, Finn WG, Goolsby CL, et al. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukaemia. Am J Clin Pathol 1999;111:123-130.
9. Geisler CH, Larsen JK, Hansen NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukaemia. Blood 1991;78:1795-1802.
10. Shapiro JL, Miller ML, Pohlman B, et al. CD5- B-Cell lymphoproliferative disorders presenting in blood and bone marrow. Am J Clin Pathol 1999;111:477-487.
11. Wang C, Amato D, Fernandes BCD. -5 negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS). Am J Hematol 2002;69: 147-149.
12. Sheikh SS, Kallakury BV, Al-Kuraya KA, et al. CD5-negative, CD10-negative small B-cell leukemia: Variant of chronic lymphocytic leukemia or a distinct entity? Am J Hematol 2002;71:306-310.
13. Ikematsu W, Ikematsu H, Okamura S, et al. Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: Expression of myelomonocytic surface markers in CD5- chronic B-cell leukaemia. Blood 1994;83:2602-2610.
14. De Rossi G, Mauro FR, Lo Coco F, et al. CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 cases. Nouv Rev Fr Hematol 1993;35:451-455.
15. Cartron G, Linassier C, Bremond JL, et al. CD5 negative B-cell chronic lymphocytic leukemia: Clinical and biological features of 42 cases. Leuk Lymphoma 1998;31:209-216.
16. Salomon-Nguyen F, Valensi F, Merle-Beral H, Flandrin G. A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL. Leuk Lymphoma 1995;16:445-450.
17. Arcaini L, Lazzarino M, Colombo N, et al. Splenic marginal zone lymphoma: A prognostic model for clinical use. Blood 2006;107:4643-4649.
18. Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia. Ann Intern Med 1989;110:236-238.
19. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
20. Baldini L, Fracchiolla NS, Cro LM, et al. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. Blood 1994;84:270-278.
21. Mitelman F. Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1991.
22. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications; 1987. pp 408-420.
23. Kaplan EI, Meier P. Non parametric evaluation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
25. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
26. Hosmer DW, Lemeshow S. Applied Survival Analysis. New York: Wiley Interscience; 1999. pp 158-180.
27. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
28. Cox DR, Snell EJ. A general definition of residuals. J R Stat Soc [B] 1968;30:248-275.
29. Hosmer DW, Lemeshow S. Applied Survival Analysis. New York: Wiley Interscience; 1999. pp 225-230.
30. Sauerbrei W, Schumacher M. A bootsrap resampling procedure for model building: Application to the Cox regression model. Stat Med 1992;11:2093-2109.
31. StataCorp. Stata Statistical Software: Release 8. College Station, TX: StataCorp; 2003.